Literature DB >> 10066018

Cerebrospinal fluid shunt infection in children: efficiency of management protocol, rate of persistent shunt colonization, and significance of 'off-antibiotics' trial.

K C Wang1, H J Lee, J N Sung, B K Cho.   

Abstract

To evaluate the efficiency of our management protocol, 33 pediatric cases of bacteria-infected cerebrospinal fluid shunt were reviewed. The causative organism was staphylococcus in 23 patients. In 23 patients, shunt infection was managed according to the protocol. The complexity of the shunt system did not prolong hospitalization. Unchanged but externalized tubings showed persistent colonization despite adequate antibiotics in 10 of 21 patients. Staphylococcal infection was oxacillin-resistant in 7 of 19. The efficiency of an 'off-antibiotics' trial was minimal. Further modification of the protocol is expected to enhance efficiency of the management.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066018     DOI: 10.1007/s003810050324

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  3 in total

1.  Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years.

Authors:  Joon Kee Lee; Joon Young Seok; Joon Ho Lee; Eun Hwa Choi; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang; Hoan Jong Lee
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

2.  Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections.

Authors:  Josef Peter Guggenbichler; Ojan Assadian; Michael Boeswald; Axel Kramer
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15

3.  An experimental in-vivo canine model for adult shunt infection.

Authors:  Roger Bayston; Christine Brant; Stephen M Dombrowski; Geraldine Hall; Marion Tuohy; Gary Procop; Mark G Luciano
Journal:  Cerebrospinal Fluid Res       Date:  2008-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.